Emergence in Taiwan of novel imipenem-resistant Acinetobacter baumannii ST455 causing bloodstream infection in critical patients

Journal of Microbiology, Immunology and Infection

Volumn 48, Issue 6, 2015, Pages 588-596

  Lee, Hao Yuan ^a   Huang, Chih Wei ^a   Chen, Chyi Liang ^a   Wang, Yi Hsin ^a   Chang, Chee Jen ^a   Chiu, Cheng Hsun ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Acinetobacter baumannii; Bacteremia; Imipenem resistance; Mortality; Sequence type

Indexed keywords

COLISTIN; IMIPENEM; SULTAMICILLIN; TIGECYCLINE; ANTIINFECTIVE AGENT; SPACER DNA;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL GENE; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; FEMALE; HOSPITAL INFECTION; HUMAN; IMIPENEM RESISTANT ACINETOBACTER BAUMANNII; IMIPENEM SUSCEPTIBLE ACINETOBACTER BAUMANNII; INTENSIVE CARE UNIT; MALE; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; RISK FACTOR; SPUTUM CULTURE; TAIWAN; VENTILATOR ASSOCIATED PNEUMONIA; ACINETOBACTER INFECTIONS; CROSS INFECTION; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; PATHOLOGY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; CROSS INFECTION; DNA, INTERGENIC; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; IMIPENEM; INTENSIVE CARE UNITS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; TAIWAN;

EID: 84952874503     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2015.03.003     Document Type: Article

References (33)

1. Peleg A.Y., Seifert H., Paterson D.L. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008, 21:538-582.
2. Sheng W.H., Liao C.H., Lauderdale T.L., Ko W.C., Chen Y.S., Liu J.W., et al. A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii. Int J Infect Dis 2010, 14:e764-e769.
3. OXA-51-like genes. J Clin Microbiol 2010, 48:2476-2483.
4. Bartual S.G., Seifert H., Hippler C., Luzon M.A., Wisplinghoff H., Rodríguez-Valera F. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol 2005, 43:4382-4390.
5. Diancourt L., Passet V., Nemec A., Dijkshoorn L., Brisse S. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One 2010, 5:e10034.
6. Zarrilli R., Pournaras S., Giannouli M., Tsakris A. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int J Antimicrob Agents 2013, 41:11-19.
7. Bonten M.J., Kollef M.H., Hall J.B. Risk factors for ventilator-associated pneumonia: from epidemiology to patient management. Clin Infect Dis 2004, 38:1141-1149.
8. Bekaert M., Timsit J.F., Vansteelandt S., Depuydt P., Vésin A., Garrouste-Orgeas M., et al. Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis. Am J Respir Crit Care Med 2011, 184:1133-1139.
9. Chuang Y.C., Sheng W.H., Li S.Y., Lin Y.C., Wang J.T., Chen Y.C., et al. Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with acinetobacter bacteremia. Clin Infect Dis 2011, 52:352-360.
10. Lee Y.T., Kuo S.C., Yang S.P., Lin Y.T., Tseng F.C., Chen T.L., et al. Impact of appropriate antimicrobial therapy on mortality associated with Acinetobacter baumannii bacteremia: relation to severity of infection. Clin Infect Dis 2012, 55:209-215.
11. Chang H.C., Wei Y.F., Dijkshoorn L., Vaneechoutte M., Tang C.T., Chang T.C. Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. J Clin Microbiol 2005, 43:1632-1639.
12. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing: twenty-first informational supplement 2013, CLSI document M100-S23, Clinical and Laboratory Standards Institute, Wayne, PA.
13. Jones R.N., Ferraro M.J., Reller L.B., Schreckenberger P.C., Swenson J.M., Sader H.S. Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp. J Clin Microbiol 2007, 45:227-230.
14. Feil E.J., Li B.C., Aanensen D.M., Hanage W.P., Spratt B.G. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol 2004, 186:1518-1530.
15. Peleg A.Y., Potoski B.A., Rea R., Adams J., Sethi J., Capitano B., et al. Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report. J Antimicrob Chemother 2007, 59:128-131.
16. Tenover F.C., Arbeit R.D., Goering R.V., Adams J., Sethi J., Capitano B., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis criteria for bacterial strain typing. J Clin Microbiol 1995, 33:2233-2239.
17. Lee H.Y., Chang R.C., Su L.H., Liu S.Y., Wu S.R., Chuang C.H., et al. Wide spread of Tn2006 in an AbaR4-type resistance island among carbapenem-resistant Acinetobacter baumannii clinical isolates in Taiwan. Int J Antimicrob Agents 2012, 40:163-167.
18. Al-Agamy M.H., Khalaf N.G., Tawfick M.M., Shibl A.M., Kholy A.E. Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt. Int J Infect Dis 2014, 22:49-54.
19. Lee H.Y., Chen C.L., Wu S.R., Huang C.W., Chiu C.H. Risk factors and outcome analysis of Acinetobacter baumannii complex bacteremia in critical patients. Crit Care Med 2014, 42:1081-1088.
20. Tada T., Miyoshi-Akiyama T., Shimada K., Shimojima M., Kirikae T. Dissemination of 16S rRNA methylase ArmA-producing Acinetobacter baumannii and emergence of OXA-72 carbapenemase coproducers in Japan. Antimicrob Agents Chemother 2014, 58:2916-2920.
21. Wisplinghoff H., Hippler C., Bartual S.G., Haefs C., Stefanik D., Higgins P.G., et al. Molecular epidemiology of clinical Acinetobacter baumannii and Acinetobacter genomic species 13TU isolates using a multilocus sequencing typing scheme. Clin Microbiol Infect 2008, 14:708-715.
22. Chuang Y.C., Sheng W.H., Lauderdale T.L., Li S.Y., Wang J.T., Chen Y.C., et al. Molecular epidemiology, antimicrobial susceptibility and carbapenemase resistance determinants among Acinetobacter baumannii clinical isolates in Taiwan. J Microbiol Immunol Infect 2014, 47:324-332.
23. Chen C.M., Ke S.C., Li C.R., Chang C.C. The comparison of genotyping, antibiogram, and antimicrobial resistance genes between carbapenem-susceptible and-resistant Acinetobacter baumannii. Comp Immunol Microbiol Infect Dis 2014, 37:339-346.
24. Runnegar N., Sidjabat H., Goh H.M., Nimmo G.R., Schembri M.A., Paterson D.L. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a single institution over a 10-year period. J Clin Microbiol 2010, 48:4051-4056.
25. Kim D.H., Choi J.Y., Kim H.W., Kim S.H., Chung D.R., Peck K.R., et al. Spread of carbapenem-resistant Acinetobacter baumannii global clone 2 in Asia and AbaR-type resistance islands. Antimicrob Agents Chemother 2013, 57:5239-5246.
26. Ruan Z., Chen Y., Jiang Y., Zhou H., Zhou Z., Fu Y., et al. Wide distribution of CC92 carbapenem-resistant and OXA-23-producing Acinetobacter baumannii in multiple provinces of China. Int J Antimicrob Agents 2013, 42:322-328.
27. He C., Xie Y., Fan H., Kang M., Tao C., Zhang R., et al. Spread of imipenem-resistant Acinetobacter baumannii of European clone II in Western China. Int J Antimicrob Agents 2011, 38:257-260.
28. Adams-Haduch J.M., Onuoha E.O., Bogdanovich T., Tian G.B., Marschall J., Urban C.M., et al. Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States. J Clin Microbiol 2011, 49:3849-3854.
29. Davies T.A., Marie Queenan A., Morrow B.J., Shang W., Amsler K., He W., et al. Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the U. S. A. in 2007-2009. J Antimicrob Chemother 2011, 66:2298-2307.
30. Tan S.Y., Chua S.L., Liu Y., Høiby N., Andersen L.P., Givskov M., et al. Comparative genomic analysis of rapid evolution of an extreme-drug-resistant Acinetobacter baumannii clone. Genome Biol Evol 2013, 5:807-818.
31. Clímaco E.C., Oliveira M.L., Pitondo-Silva A., Oliveira M.G., Medeiros M., Lincopan N., et al. Clonal complexes 104, 109 and 113 playing a major role in the dissemination of OXA-carbapenemase-producing Acinetobacter baumannii in Southeast Brazil. Infect Genet Evol 2013, 19:127-133.
32. Ramírez M.S., Vilacoba E., Stietz M.S., Merkier A.K., Jeric P., Limansky A.S., et al. Spreading of AbaR-type genomic islands in multidrug resistance Acinetobacter baumannii strains belonging to different clonal complexes. Curr Microbiol 2013, 67:9-14.
33. Stietz M.S., Ramírez M.S., Vilacoba E., Merkier A.K., Limansky A.S., Centrón D., et al. Acinetobacter baumannii extensively drug resistant lineages in Buenos Aires hospitals differ from the international clones I-III. Infect Genet Evol 2013, 14:294-301.